Health

  • April 22, 2026

    Bayer 'Natural' Vitamin Buyer Classes Affirmed By 9th Circ.

    A split Ninth Circuit on Tuesday upheld a federal district court's certification of New York and California classes of consumers who bought Bayer Healthcare multivitamin gummies that were allegedly labeled falsely as "natural," finding the company "demands more" from the plaintiffs at this stage of the litigation than certification requires. 

  • April 22, 2026

    Workers' Attys Get $940K As $4.7M Tobacco Deal Approved

    A Virginia federal judge on Wednesday awarded $940,000 in attorney fees to class counsel who secured a $4.7 million settlement with food distributor Performance Food Group over claims that it unlawfully charged tobacco users an extra fee for health benefits.

  • April 22, 2026

    Eli Lilly Case Over Weight Loss Drugs Kept Mostly Intact

    A California federal court has refused to throw out a lawsuit from Eli Lilly against a telehealth company and related entities over the compounding of its popular weight loss drugs Mounjaro and Zepbound, but agreed to trim a conspiracy claim from the case.

  • April 22, 2026

    Justices Would Back Vax Law Challenge, 2nd Circ. Told

    The U.S. Supreme Court's March 2 decision in a California gender-related school policy case requires the Second Circuit to advance a 2023 challenge to Connecticut's preschool and daycare student vaccine mandates, an attorney for a Constitution State congregation told a three-judge panel on Wednesday.

  • April 22, 2026

    5th Circ. Bars Dead Veteran's VA Surgery Suit As Untimely

    The estate of a dead veteran who filed a medical malpractice lawsuit 18 years after an unauthorized operation at a Veterans Affairs hospital didn't bring the suit within Mississippi's seven-year deadline for medical malpractice claims, the Fifth Circuit ruled Wednesday.

  • April 22, 2026

    Judge Lets Pharma Co. Seal Parts Of Ex-GC's Retaliation Suit

    A Texas state judge on Wednesday granted Houston-based Empower Clinic Services LLC's bid to permanently and partially seal a petition by its former general counsel that alleges a smear campaign by the company after he confronted them about conduct he said was unlawful.

  • April 22, 2026

    Sorrento, M3 Get Pause On RICO Suit Naming Jackson Walker

    A Texas bankruptcy judge on Wednesday agreed to put on hold a lawsuit in California federal court alleging Jackson Walker LLP and executives at Sorrento Therapeutics and M3 Partners conspired to forum shop in Texas so the drug developer could seek Chapter 11 protection there.

  • April 22, 2026

    Simpson Thacher Adds Another Kirkland Finance Alum In Calif.

    Simpson Thacher & Bartlett LLP has hired another former Kirkland & Ellis LLP partner to join its recently formed capital structure solutions practice in the San Francisco area, where she'll focus on banking and other finance matters, Simpson Thacher announced Wednesday.

  • April 22, 2026

    Commure Took Health Co.'s Software Trade Secrets, Suit Says

    A San Diego-based healthcare technology services company has accused Commure Inc. of stealing trade secrets to launch competing cloud-based software, framing the alleged conduct as an instance of a large company "backed by big money" breaking the rules to obtain a much smaller competitor's information.

  • April 22, 2026

    Ex-Conn. Prosecutor Fights Drug Co. Bid To Appeal DQ Denial

    Insurers Humana Inc. and Molina Healthcare Inc. urged a federal judge to turn down a group of generic-drug makers' request for an immediate trip to the Third Circuit, arguing the drugmakers' bid for a second chance to disqualify Connecticut's former assistant attorney general from an antitrust case was not qualified for an interlocutory appeal.

  • April 22, 2026

    Kirkland Keeps Growing In Philly With Private Equity Atty

    Kirkland & Ellis LLP announced Wednesday it is continuing to expand its new Philadelphia office with the recent addition of a private equity attorney, who has moved his practice after more than 12 years with Morgan Lewis & Bockius LLP.

  • April 22, 2026

    4 Firms Build Amneal's Up To $1.1B Kashiv Biosimilars Buy

    Biopharmaceutical company Amneal Pharmaceuticals Inc. on Wednesday unveiled plans to acquire biosimilars-focused Kashiv BioSciences LLC in a deal worth up to $1.1 billion that was built by four law firms.

  • April 22, 2026

    Life Policy With $21M Payout Voided As Illegal Life Wager

    A Delaware federal court voided a life insurance policy as an unlawful wager on a now-deceased Florida woman's life, finding that Ameritas Life Insurance Corp. is entitled to retain the policy's $10 million death benefit and $11 million in premium payments.

  • April 22, 2026

    Healthcare REIT Raises $462M In IPO Advised By 4 Firms

    Healthcare-focused real estate investment trust National Healthcare Properties began trading Wednesday after raising $462 million in an initial public offering guided by Paul Weiss, Greenberg Traurig LLP, Sidley Austin LLP and Venable LLP.

  • April 21, 2026

    Nourish Can't Ax Wiretap Claims In Google Data Sharing Row

    An Illinois federal judge has refused to cut wiretap and negligence claims from a proposed class action accusing telehealth provider Nourish Inc. of deploying tracking tools that illegally transmitted website visitors' sensitive health information to Google, while tossing several privacy and contract allegations and rebuking the plaintiffs for filing a "press release complaint."

  • April 21, 2026

    Georgia Panel Tosses $123K Fee Award After Defense Win

    A Georgia appellate panel tossed on Tuesday an award of $123,000 in attorney fees to defense counsel after their win in a medical malpractice trial, ruling that a state judge failed to show how she arrived at the figure.

  • April 21, 2026

    Congress Rallies More For Bills On Copyrights Than Patents

    There have been more intellectual property bills floated in Congress that are supportive of copyright rights than patent rights, according to a new report looking at how lawmakers treat the IP system.

  • April 21, 2026

    Amgen Faces ERISA Suit Over Health Plan Tobacco Surcharge

    A former Amgen Inc. employee filed a proposed class action in California federal court Tuesday alleging the biotech company discriminatorily imposes an "egregiously high" $150-a-month surcharge on employees who use tobacco products, while failing to adequately notify them of reasonable pathways to avoid the fees, in violation of federal benefits law.

  • April 21, 2026

    ProMedica Wins Bid To Unseal Gov't Probe Briefs In FCA Suit

    Nursing home operator ProMedica Health Systems Inc. has succeeded in its bid to unseal government briefs in a whistleblower case over alleged problems caused by understaffing at its facilities, with a Pennsylvania federal judge ruling that a presumption of openness with court records trumped the government's concerns about disclosure of its investigative methods.

  • April 21, 2026

    Watchdog Says Ex-Fla. Rep Used Straw Donors For Campaign

    A Washington, D.C.-based watchdog organization accused former Florida Rep. Sheila Cherfilus-McCormick of improperly funding her 2022 reelection bid to the U.S. House of Representatives, saying she orchestrated a complex straw donor scheme to funnel $725,000 in Haitian "dark money" into her campaign. 

  • April 21, 2026

    Defendant Says Rx Software Was Guide For Docs, Not Fraud

    A man accused of swindling Medicare out of nearly half a billion dollars was simply trying to make it easier for doctors to navigate labyrinthine Medicare regulations to get orthotic braces approved for their patients, his attorney told jurors in Florida federal court Tuesday.

  • April 21, 2026

    Woman Pleads Guilty In $51M Medicare Fraud Scheme

    A San Diego woman has pled guilty in California federal court to billing Medicare for nearly $51 million in fake prescriptions and trying to hide the scheme through money laundering and kickbacks to doctors.

  • April 21, 2026

    Feds Say Pot Foes Lack Standing To Stop CMS Hemp Program

    Federal health regulators have told a D.C. federal judge that anti-pot advocates' attempt to block a program to ease access for Medicare beneficiaries to federally legal hemp products that have small amounts of THC was not bolstered by the addition of a pharmaceutical company as a co-plaintiff.

  • April 21, 2026

    Fed. Circ. Keeps Banner Witcoff And Saiber Off Patent Case

    The Federal Circuit kept intact the disqualification of two law firms from a patent ownership fight on Tuesday, saying it had not been shown a district judge made a clear error in removing them.

  • April 21, 2026

    2nd Circ. Chilly To Additional Discovery In Cigna Pension Suit

    The Second Circuit on Tuesday seemed reluctant to restart proceedings in a long-running suit against Cigna from retirees who challenged changes to their pensions, appearing unwilling to upend a decision to turn down post-judgment discovery in the class action.

Expert Analysis

  • Trans Care Enforcement Landscape Is Evolving Quickly

    Author Photo

    The recent coordinated federal effort to reshape pediatric gender-affirming care through enforcement and funding pressure has created a rapidly evolving regulatory environment marked by shifting risk assessments and potential downstream market effects for healthcare institutions and life sciences companies, say attorneys at Arnall Golden.

  • Series

    Playing Piano Makes Me A Better Lawyer

    Author Photo

    Playing piano and practicing law share many parallels relating to managing complexity: Just as hearing an entire musical passage in my head allows me to reliably deliver the message, thinking about the audience's impression helps me create a legal narrative that keeps the reader engaged, says Michael Shepherd at Fish & Richardson.

  • 11th Circ. May Bring Tectonic Shift To FCA Qui Tam Actions

    Author Photo

    The Eleventh Circuit's upcoming decision in Zafirov v. Florida Medical Associates, assessing whether the False Claims Act permits ordinary citizens to stand as officers of the federal government, could significantly limit private relators' ability to bring FCA actions, say attorneys at Saul Ewing.

  • AI-Generated Doc Ruling Guides Attys On Privilege Risks

    Author Photo

    A New York federal court's ruling, in U.S. v. Heppner, that documents created by a defendant using an artificial intelligence tool were not privileged, can serve as a guide to attorneys for retaining attorney-client or work-product privilege over client documents created with AI, say attorneys at Sher Tremonte.

  • To Survive FCA Actions, Small Cos. Must Take Offensive Steps

    Author Photo

    A fumbled response to False Claims Act allegations can doom lower-middle-market businesses, and with FCA enforcement hitting record levels for two years, smaller companies must have offensive strategies ready that focus their limited resources on defeating civil qui tam and federal criminal actions, says Derrelle Janey at Olshan Frome.

  • The Law Firm Merger Diaries: Leadership Strategy After Day 1

    Author Photo

    For law firm leaders, ensuring a newly combined law firm lives up to its promise, both in its first days of operation and well after, includes tough decisions, clear and specific communication, and cheerleading, says Peter Michaud at Ballard Spahr.

  • How US Liability Law Is Becoming The Primary Regulator Of AI

    Author Photo

    Comprehensive federal AI regulation remains fragmented and uncertain — but U.S. courts, applying long-standing doctrines of liability and responsibility, are actively shaping how AI systems are designed, deployed and governed, and companies are aligning their AI practices because courts may hold them accountable if they do not, says Alexander Lima at Wesco International.

  • Record FCA Recoveries Signal Intensified Healthcare Focus

    Author Photo

    In its recently released False Claims Act statistics, the U.S. government's emphasis on record healthcare recoveries and government-initiated healthcare matters last year indicates robust enforcement ahead, though the administration's focus on current policy objectives also extends beyond the healthcare sector, say attorneys at Epstein Becker.

  • Fed. Circ. In Jan.: On The Validity Of Expert Testimony

    Author Photo

    The Federal Circuit's recent decision in Barry v. DePuy, addressing whether expert testimony is admissible even if it does not strictly adhere to the court's claim construction, suggests that exclusion via a Daubert motion is appropriate only when the line to improper testimony is clearly crossed, say attorneys at Knobbe Martens.

  • Methods For Challenging State Civil Investigative Demands

    Author Photo

    Ongoing challenges to enforcement actions underscore the uphill battle businesses face in arguing that a state investigation is prohibited by federal law, but when properly deployed, these arguments present a viable strategy to resist civil investigative demands issued by state attorneys general, say attorneys at Troutman Pepper.

  • Calif.'s Civility Push Shows Why Professionalism Is Vital

    Author Photo

    The California Bar’s campaign against discourteous behavior by attorneys, including a newly required annual civility oath, reflects a growing concern among states that professionalism in law needs shoring up — and recognizes that maintaining composure even when stressed is key to both succeeding professionally and maintaining faith in the legal system, says Lucy Wang at Hinshaw.

  • A Potential Shift In FDA's Approach To Drug Trial Design

    Author Photo

    Recent guidance released by the U.S. Food and Drug Administration clarifying how Bayesian approaches — which combine prior knowledge with new data — may be used in clinical trials reflects the agency's continued interest in innovative trial designs that may accelerate drug approvals, say attorneys at Alston & Bird.

  • Opinion

    SNAP Rule Confusion Risks A Compliance Crisis

    Author Photo

    Recent Supplemental Nutrition Assistance Program food restriction waivers pose a compliance crisis for legal practitioners advising food retailers, amid higher costs and lack of a coherent national standard, says Tyson-Lord Gray at Yeshiva University’s Benjamin N. Cardozo School of Law.

  • Series

    Trivia Competition Makes Me A Better Lawyer

    Author Photo

    Playing trivia taught me to quickly absorb information and recognize when I've learned what I'm expected to know, training me in the crucial skills needed to be a good attorney, and reminding me to be gracious in defeat, says Jonah Knobler at Patterson Belknap.

  • What FDA Guidance Means For Future Of Health Software

    Author Photo

    Two significant final guidance documents released by the U.S. Food and Drug Administration last month reflect a targeted effort to ease innovation friction around specific areas, including singular clinical decision support recommendations and sensor-based wearables, while maintaining established regulatory boundaries, say attorneys at Covington.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.